G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Market Cap	3.48B
Revenue (ttm)	211.15M
Net Income (ttm)	83.82M
Shares Out	59.00M
EPS (ttm)	1.42
PE Ratio	41.53
Forward PE	n/a
Dividend	0.54 (0.92%)
Ex-Dividend Date	n/a

Volume	60,780
Average Volume	25,109
Open	58.90
Previous Close	58.60
Day's Range	58.50 - 59.30
52-Week Range	48.58 - 61.70
Beta	-0.18
RSI	65.35
Earnings Date	Mar 21, 2025

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products. It offers Hepanamin capsules; botoniocal healthcare products; botanical anti-aging cosmetics, which includes facial cleansing essence, botonic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; and adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 37
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4911

Financial Performance

In 2023, G&E Herbal Biotechnology's revenue was 181.44 million, an increase of 180.84% compared to the previous year's 64.61 million. Earnings were 72.40 million, an increase of 880.90%.